Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20043261HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20017750HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20038791HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20053858HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20053624HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20015273HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20015272HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20015536HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20014966HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TVIS20015563HPVENSG00000171791.14protein_codingBCL2YesNo596P10415
TCGA Plot Options
Drug Information
GeneBCL2
DrugBank IDDB08871
Drug NameEribulin
Target IDBE0000246
UniProt IDP10415
Regulation Type
PubMed IDs15313917
CitationsKuznetsov G, Towle MJ, Cheng H, Kawamura T, TenDyke K, Liu D, Kishi Y, Yu MJ, Littlefield BA: Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389. Cancer Res. 2004 Aug 15;64(16):5760-6.
GroupsApproved; Investigational
Direct Classification
SMILES[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@H]7O[C@@]8(C[C@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2
Pathways
PharmGKB
ChEMBLCHEMBL1683590